Hepatocellular carcinoma with gastric adenocarcinoma treated with atezolizumab and bevacizumab.
Takayoshi SugaYuko KimuraKensuke FuruyaHiroko SatoPublished in: Clinical case reports (2023)
Atezolizumab and bevacizumab combination therapy might be one of the treatment options for hepatocellular carcinoma concurrent with gastric adenocarcinoma.